EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 3.0

cGAS-STING and PANoptosis: Interplay, Underlying Mechanisms, and Therapeutic Targets

Yumin Wang iD, Jinxia Chen, Wenxin Feng, Ning Li, Xiu Zhang, Shuang Zhao, Kerui Shi, Erdan Wang, Yuzi Jin

Drug Design, Development and Therapy · 2026

DOI: 10.2147/dddt.s593380 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Drug Design, Development and Therapy, 2026. Verfasst von Yumin Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, Aerospace Center Hospital, Peking University Aerospace School of Clinical Medicine, Beijing, Pe…. Hauptthemen laut MEDLINE: Nucleotidyltransferases, Membrane Proteins, Inflammation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 148 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The cGAS-STING pathway is an essential cytosolic DNA sensing mechanism that activates innate immune responses upon detection of microbial or aberrant self-DNA. This evolutionarily conserved signaling axis plays critical roles in autoimmune diseases, sterile inflammation, and cellular senescence. While its transient activation provides protective immunity, dysregulated cGAS-STING signaling contributes to the pathogenesis of various inflammatory and autoimmune conditions. Growing evidence indicates its functional convergence with multiple cell death pathways-particularly PANoptosis, a distinct inflammatory programmed cell death (PCD) pathway that integrates key features of pyroptosis, apoptosis, and necroptosis. The dynamic interplay between cGAS-STING signaling and PANoptosis has emerged as an important pathogenic mechanism across multiple diseases, revealing new therapeutic opportunities. In this review, we propose a unifying conceptual framework in which cGAS-STING activation functions as a predominant upstream driver of PANoptosis across diverse pathological contexts, orchestrated through a convergent molecular axis involving cytosolic DNA sensing, ZBP1-PANoptosome assembly, and coordinated inflammatory cell death. We begin by outlining the core molecular architecture of the cGAS-STING pathway and its implications in disease. We then examine the mechanisms and pathophysiological consequences of cGAS-STING -PANoptosis crosstalk in various disorders, followed by recent advances in therapeutic strategies specifically targeting this interface. Finally, we discuss translational challenges, such as the poor bioavailability and systemic toxicity of conventional STING agonists, and highlight innovative solutions including nanomedicine-based delivery systems that enable tumor-specific activation while minimizing off-target effects. By highlighting the therapeutic potential of pharmacological modulation at this junction, we identify promising strategies for treating inflammation-associated diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NucleotidyltransferasesMembrane ProteinsInflammationHumanscGAS-STING Signaling PathwayCyclic Guanosine Monophosphate-Adenosine Monophosphate SynthaseAnimalsSTING ProteinAutoimmune DiseasesSignal TransductionApoptosisImmunity, Innate

Stichwörter der Autor:innen

PANoptosisProgrammed cell deathcGAS-STINGcrosstalk

Substanzen

NucleotidyltransferasesCyclic Guanosine Monophosphate-Adenosine Monophosphate SynthaseMembrane ProteinsSTING ProteincGAS protein, humanSTING1 protein, human

Autor:innen und Institutionen

  • Department of Respiratory and Critical Care Medicine, Aerospace Center Hospital, Peking University Aerospace School of Clinical Medicine, Beijing, People's Republic of China.
  • Department of Blood Transfusion, The Fourth Hospital of Hebei Medical University, Shijiazhuang, People's Republic of China.
  • Department of Anesthesiology, Basic Medical College, Guangxi Medical University, Nanning, People's Republic of China.
  • Department of Biochemistry and Molecular Biology, Shenyang Medical College, Liaoning Province Key Laboratory for Phenomics of Human Ethnic Specificity and Critical Illness(LPKL-PHESCI), Shenyang Key Laboratory for Pheno…
  • Department of Stomatology, Shenyang Medical College, Liaoning Province Key Laboratory for Phenomics of Human Ethnic Specificity and Critical Illness (LPKL -PHESCI), Shenyang Key Laboratory for Phenomics, Shenyang, Peopl…
  • Laboratory Animal Center, Affiliated Hospital of Chengde Medical University, Chengde, People's Republic of China.

ORCID-Profile: Yumin Wang

Zitieren

APA

Wang, Y., Chen, J., Feng, W., Li, N., Zhang, X., Zhao, S., Shi, K., Wang, E., & Jin, Y. (2026). cGAS-STING and PANoptosis: Interplay, Underlying Mechanisms, and Therapeutic Targets. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s593380

Vancouver

Wang Y, Chen J, Feng W, Li N, Zhang X, Zhao S, et al. cGAS-STING and PANoptosis: Interplay, Underlying Mechanisms, and Therapeutic Targets. Drug Design, Development and Therapy. 2026. doi:10.2147/dddt.s593380

BibTeX
@article{Wang2026,
  author = {Wang, Yumin and Chen, Jinxia and Feng, Wenxin and Li, Ning and Zhang, Xiu and Zhao, Shuang and Shi, Kerui and Wang, Erdan and Jin, Yuzi},
  title = {cGAS-STING and PANoptosis: Interplay, Underlying Mechanisms, and Therapeutic Targets},
  journal = {Drug Design, Development and Therapy},
  year = {2026},
  doi = {10.2147/dddt.s593380}
}
Kostenlos starten →